A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells()()

The therapeutic effect in non–small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients. In this study, the novel small molecule indolizino[6,7-b]i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840272/
https://www.ncbi.nlm.nih.gov/pubmed/27108383
http://dx.doi.org/10.1016/j.neo.2016.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840272/
https://www.ncbi.nlm.nih.gov/pubmed/27108383
http://dx.doi.org/10.1016/j.neo.2016.02.005

Ejemplares similares